Bates, D., Maechler, M., Bolker, B
2023: Lawsuits are filed against Novo Nordisk on behalf of patients who took the drugs and developed gastroparesis/stomach paralysis problems Pop Culture Weight Loss Phenomenon Is Paralyzing Peoples Stomachs FDA, Scientific Studies and Literature on Ozempic, Wegovy, and Rybelsus Gastroparesis/Stomach Paralysis The below studies constitute a small sampling of the scientific literature and studies published on the diabetes weight-loss drugs and gastroparesis/stomach paralysis: Jensterle et al (2023) : Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity This was a small clinical trial of 20 obese female patients with polycystic ovary syndrome who were given semaglutide or placebo
Frequently Asked Questions (FAQs) Generally, Tirzepatide is recommended for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition (such as high blood pressure, high cholesterol, or sleep apnea)
Febbraio, M
Roh MR, Gupta S, Park KH, Chung KY, Lauss M, Flaherty KT et al
